Get the app!
Back to Trades

Krempa David

Chief Business OfficerCIK 0001968254

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
8
Buy transactions
0
Sell transactions
7
Companies
1
Active
2025–2026

Krempa David, Chief Business Officer, has filed 8 SEC reports (2025–2026), all concentrated in Eton Pharmaceuticals, Inc. (ETON), totaling $6.6M in disclosed volume. Weighing $0 bought versus $5.1M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

8 loaded
Oct 6ETON
Eton Pharmaceuticals, Inc.
Krempa DavidChief Business OfficerSell$229.4K
Aug 24ETON
Eton Pharmaceuticals, Inc.
Krempa DavidChief Business OfficerSell$1.6M
Aug 4ETON
Eton Pharmaceuticals, Inc.
Krempa DavidChief Business OfficerAward$0
Jul 13ETON
Eton Pharmaceuticals, Inc.
Krempa DavidChief Business OfficerExercise$0
Jun 30ETON
Eton Pharmaceuticals, Inc.
Krempa DavidChief Business OfficerAward$0
May 27ETON
Eton Pharmaceuticals, Inc.
Krempa DavidChief Business OfficerSell$3.2M
Jan 14ETON
Eton Pharmaceuticals, Inc.
Krempa DavidChief Business OfficerAward$659.3K
Dec 12ETON
Eton Pharmaceuticals, Inc.
Krempa DavidChief Business OfficerAward$106.5K

8 filings